Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Immuron (IMRN) Interest Coverage Ratio (2017 - 2024)

Immuron's quarterly Interest Coverage Ratio came in at 631383620.69 in Q4 2024, down 125243619.8% year-on-year from N/an in Q1 2024, and down 125243619.8% quarter-over-quarter from 504.12 in Q4 2023.

Immuron has reported Interest Coverage Ratio for 7 years, with the latest figure at 631383620.69 in Q4 2024.

  • For the quarter ending Q4 2024, Interest Coverage Ratio fell 125243619.8% year-over-year to 631383620.69; the trailing twelve-month figure through Dec 2024 stood at 631382658.57 (down 19171.51% YoY), and the FY2025 full-year result was 731.63, up 4.45% from the prior year.
  • Interest Coverage Ratio for Q4 2024 stood at 631383620.69, down from 504.12 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 1396085889.57 in Q4 2021, with the low at 631383620.69 in Q4 2024.
  • Average Interest Coverage Ratio over 5 years is 152940699.68, with a median of 504.12 recorded in 2023.
  • Year-over-year, Interest Coverage Ratio soared 193212570.22% in 2021 and tumbled 125243619.8% in 2024.
  • Tracing IMRN's Interest Coverage Ratio over 5 years: stood at 722.56 in 2020, then soared by 193212570.22% to 1396085889.57 in 2021, then plunged by 100.0% to 2.83 in 2022, then surged by 17736.64% to 504.12 in 2023, then plunged by 125243619.8% to 631383620.69 in 2024.
  • The last three Interest Coverage Ratio figures came in at 631383620.69 (Q4 2024), 504.12 (Q4 2023), and 2.83 (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -129.79
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -258.33
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 11.50
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.88
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -631.38 Mn
Dec 31, 2023 504.12
Dec 31, 2022 2.83
Dec 31, 2021 1.40 Bn
Dec 31, 2020 722.56
Dec 31, 2019 647.54
Dec 31, 2017 -1,306.58